Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)
G.J. Morgan*, F.E. Davies, W.M. Gregory, S.E. Bell, A.J. Szubert, N. Navarro Coy, A.J. Ashcroft, M.T. Drayson, R.G. Owen, G.H. Jackson, J.A. ChildVolume:
48
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2010.10.043
File:
PDF, 72 KB
english, 2011